oncodaily - Eikon Therapeutics has raised $381 million through its IPO, pricing at the top of its range in a strong sign of renewed investor appetite for biotech offerings. The South San […]
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment
Saturday, February 7, 2026, 1:21 am / permalink 18871 / 2 stories in 5 wks
EPA proposes rollback on ethylene oxide sterilizer emissions (16 min)
Two deaths prompt probe of paid plasma donation clinics in Winnipeg (1 hr)
HIMSS 2026 pushes real‑time data, cloud and interoperability playbook (18 hrs)
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.